Sareum Share News (SAR)

Sareum Information

Buy SAR Shares
Add SAR to Watchlist
Add SAR to Alert

Share Price Information for Sareum (SAR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 24.25

Bid: 24.00

Ask: 24.50

Change: -1.00 (-3.96%)

Spread: 0.50 (2.083%)

Open: 25.25

High: 25.25

Low: 24.25

Prev. Close: 25.25

Last checked at -

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

Thu, 03rd Dec 2020 15:45

Sareum Holdings PLC - Cambridge-based specialist drug development company focused on cancer and autoimmune diseases - Receives GBP174,000 grant from UK Research & Innovation to investigate TYK2/JAK1 kinase inhibitor as a treatment for severe Covid-19. "If this research and the ongoing preclinical development of SDC-1801 is successful, and subject to further funding, Sareum would aim to begin a clinical trial of SDC-1801 in severe-phase Covid-19 patients during 2021," Sareum says.

Current stock price: 1.42 pence

Year-to-date change: up sharply from 0.36p

By Eric Cunha; ericcunha@alliancenews.com

More News

7 Oct 2021 22:08

TRADING UPDATES: Marlowe buys; Galliford snaps up nmcn's Water unit

19 Aug 2021 14:25

IN BRIEF: Sareum expects annual loss to widen, increases R&D

19 Aug 2021 07:41

Sareum expects FY losses to widen on higher R&D costs, supply delays

(Sharecast News) - British drugmaker Sareum said on Thursday that it expects to post a widened full-year loss as a result of increased research-and-development expenditure and delays in compound supply.

9 Aug 2021 17:08

TRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million

6 Aug 2021 15:00

Sareum positive on SRA737 outlook after Sierra call

(Sharecast News) - Specialist drug development company Sareum noted on Friday that Sierra Oncology, the licence holder for the novel Chk1 inhibitor 'SRA737', had discussed its newly-announced global in-licensing agreement with AstraZeneca for AZD5153 with investors, which is a novel BRD4 BET inhibitor, to expand its myelofibrosis pipeline.

30 Jul 2021 19:40

TRADING UPDATES: Capita and Custodian REIT agree disposals

30 Jul 2021 11:00

AIM WINNERS & LOSERS: Sareum in patent boost; Airea flags uncertainty

19 Jul 2021 19:13

TRADING UPDATES: Sareum raises GBP1 million; Marlowe buys Core Stream

1 Jul 2021 19:26

TRADING UPDATES: Gym Group bulks up with placing; 88 Energy debt free

1 Jul 2021 11:18

Sareum releases 'encouraging' results from Covid-19 research

(Sharecast News) - Specialist drug development company Sareum announced "encouraging" top-line results from its UKRI grant-funded Covid-19 research project on Thursday.

15 Jun 2021 20:28

TRADING UPDATES: Tremor Nasdaq IPO underway; MGC's CannEpil in Ireland

1 Jun 2021 17:43

TRADING UPDATES: Breedon buys Micromix; Marlowe acquires Alarm

1 Jun 2021 11:30

AIM WINNERS & LOSERS: Sound Energy falls on Morocco tax notification

25 May 2021 17:11

TRADING UPDATES: Mothercare sales down; Revolution Bars seeks to raise

25 May 2021 10:56

Sareum's pre-clinical development of SDC-1801 delayed by Covid-19

(Sharecast News) - Pharmaceutical company Sareum said on Tuesday that Covid-19 has continued to impact the contract research organisations it was working to complete pre-clinical development of its SDC-1801 drug candidate for autoimmune disease.

Latest Share Chat

Sareum Share News (SAR)

Share Price Information for Sareum (SAR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Sareum Gets GBP174,000 To Research Potential Virus Treatment

Login to your account

Quickpicks are a member only feature

Login to your account